Consistency: Daily, moderate doses are more effective than occasional mega-doses
In September 2023, the FDA classified BPC-157 as a Category 2 bulk drug substance under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
Glutathione is the bodys main antioxidant, and, like a firefighter, it helps prevent free radicals from worsening
The angiogenesis hypothesis may provide new insights by suggesting a decline in angiogenic growth factors with age, which in turn leads to a reduction in microcirculation in the body (Ambrose 2016)
GHK-Cu reduces the inflammatory signaling that accelerates this miniaturization process and stimulates dermal papilla cells to maintain follicle size and activity
It represents a fundamentally different approach to skin rejuvenation compared with GHK-Cu